Literature DB >> 8418369

Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Groupe Français de Cytogénétique Hématologique.

.   

Abstract

A collaborative study carried out by the Groupe Français de Cytogénétique Hématologique collected 411 successful karyotypes of childhood acute lymphoblastic leukemias. Karyotypes showed a clonal abnormality in 292 patients (71%). The distribution of ploidy groups was: pseudodiploidy in 116 karyotypes (28.2%), hyperdiploidy > 50 chromosomes in 110 karyotypes (26.8%), hyperdiploidy 47-50 chromosomes in 46 karyotypes (11.2%) and hypodiploidy in 20 karyotypes (4.9%). One-half of the patients with hyperdiploidy > 50 chromosomes also had a structural abnormality, with a partial trisomy 1q in one fourth of them. Similar translocations, candidate for new recurrent changes were identified: t(9;9)(p13;q13),t(7;9)(q11;p11),t(7;12)(q11;p12-13), t(4;12)(q13;p12), and t(1;17)(q12-21;p13). Within recurrent translocations, the three t(10;11)(p13-14;q14-21) displayed a T-cell phenotype. In T-cell leukemias, a new area of recurrent breakpoints (5q31-35) was observed and deletions 6q were more frequent in this lineage. Correlations of cytogenetic results with clinical and hematological data revealed that, within hyperdiploidy > 50 chromosomes, patients with structural changes were older than patients without. Patients with 9p changes showed some of the features usually observed in lymphomatous leukemias. Even with a short follow-up, differences in outcomes were observed. Patients with hyperdiploidy > 50 chromosomes fared the best and those with pseudodiploid karyotypes did worse than patients with other karyotypes. Patients with random translocations did not share the poor outcome of patients with recurrent translocations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418369

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  A potential role of ruxolitinib in leukemia.

Authors:  Kiran Naqvi; Srdan Verstovsek; Hagop Kantarjian; Farhad Ravandi
Journal:  Expert Opin Investig Drugs       Date:  2011-06-03       Impact factor: 6.206

2.  Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Kajsa Paulsson; Erik Forestier; Henrik Lilljebjörn; Jesper Heldrup; Mikael Behrendtz; Bryan D Young; Bertil Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

3.  Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea.

Authors:  Joonhong Park; Myungshin Kim; Hae Kyung Lee; Yonggoo Kim; Kyungja Han; Jungok Son; Seok Lee; Nack-Gyun Chung; Bin Cho
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

4.  High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols.

Authors:  Kajsa Paulsson; Erik Forestier; Mette K Andersen; Kirsi Autio; Gisela Barbany; Georg Borgström; Lucia Cavelier; Irina Golovleva; Sverre Heim; Kristiina Heinonen; Randi Hovland; Johann H Johannsson; Eigil Kjeldsen; Ann Nordgren; Lars Palmqvist; Bertil Johansson
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

5.  Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL.

Authors:  Oscar Molina; Meritxell Vinyoles; Isabel Granada; Heleia Roca-Ho; Francisco Gutierrez-Agüera; Luis Valledor; Carlos M López-López; Pablo Rodríguez-González; Juan L Trincado; Sofía T Menéndez; Deepali Pal; Paola Ballerini; Monique L den Boer; Isabel Plensa; M Mar Perez-Iribarne; Sandra Rodríguez-Perales; María José Calasanz; Manuel Ramírez-Orellana; René Rodríguez; Mireia Camós; Maria Calvo; Clara Bueno; Pablo Menéndez
Journal:  Blood       Date:  2020-07-16       Impact factor: 22.113

6.  Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Rebeqa Gunnarsson; Sebastian Dilorenzo; Kristina B Lundin-Ström; Linda Olsson; Andrea Biloglav; Henrik Lilljebjörn; Marianne Rissler; Per Wahlberg; Anders Lundmark; Anders Castor; Mikael Behrendtz; Thoas Fioretos; Kajsa Paulsson; Anders Isaksson; Bertil Johansson
Journal:  Leukemia       Date:  2018-03-12       Impact factor: 11.528

7.  Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease.

Authors:  Nisha R Singh; Christine M Morris; Mary Koleth; Kelly Wong; Christopher M Ward; William S Stevenson
Journal:  Mol Cytogenet       Date:  2013-12-17       Impact factor: 2.009

Review 8.  New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update.

Authors:  Adrián Montaño; Maribel Forero-Castro; Darnel Marchena-Mendoza; Rocío Benito; Jesús María Hernández-Rivas
Journal:  Cancers (Basel)       Date:  2018-04-07       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.